Published

Blinding and expectancy confounds in psychedelic randomized controlled trials.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Expert review of clinical pharmacology
Date: 2021-09-01
Source: PubMed
DOI: 10.1080/17512433.2021.1933434
PubMed: 34038314

Authors

Muthukumaraswamy SD Forsyth A Lumley T

Watch author

Derived topics and classifications

psilocybin Clinical Trial Randomized Controlled Trial Systematic Review Review Article Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 11 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Longitudinal neural and psychological changes following psilocybin under compassion imagery priming2026-07-22 Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview2026-07-13 Psilocybin therapy for adult females with anorexia nervosa: pilot study2026-07-08 Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression2026-06-01 Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression2026-05-15 Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care2026-05-14 Psilocybin in the Treatment of Cocaine Use Disorder2026-05-07 Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression2026-05-01 Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis2026-04-01 Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applications2026-03-01 Blinding and expectancy confounds in psychedelic randomized controlled trials.2021-09-01

Related papers

Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-AnalysisPsychiatry International · 2026-06-15 Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled TrialsOpen Access Indonesian Journal of Medical Reviews · 2026-04-21 Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2025-12-01 Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and DurationJournal of International Crisis and Risk Communication Research · 2024-12-31 Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overviewJournal of Psychedelic Studies · 2026-07-13 A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-06 PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONSInternational Journal of Innovative Technologies in Social Science · 2026-03-19